IRCT20180619040147N2 IRCT 2018-08-21 Iranian Academic Center for Education Culture and Research Evaluation of the safety and feasibility of intra ovarian injection of menstrual blood derived stem cells (MenSCs) in women with poor ovarian response. Evaluation of the safety and feasibility of intra ovarian injection of menstrual blood derived stem cells (MenSCs) in women with poor ovarian response. 2018-08-06 anticipated 36 Complete https://irct.ir/trial/31980 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomization: In order to randomly assign 36 subjects in treatment group or control group, 6 blocks including 6 subjects each will be defined using "https://app.studyrandomizer.com". Treatment group and control group will be identified by codes A and B, respectively. In each block, number of treatment group and control group is equal and situation of each block with other block is different. 1-2 Poor ovarian response. Intervention 1: Intervention group: includes 18 patients with poor ovarian response that will be treated by once injection of autologous menstrual blood stem cells. After cells isolation, culture and qualification in GMP grade- clean room of STERCO (Tehran, Iran), they will be intravaginally injected by vaginal ultrasonography into left ovary of patients after receiving general anesthesia. Intervention 2: Control group: includes 18 patients with poor ovarian response that will not receive any intervention and their biochemical parameters, sonographic and embryologic data will be compared with intervention group. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.